Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Operating Income: 2009-2025

Historic Operating Income for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $47.7 million.

  • BIO-TECHNE's Operating Income rose 19.18% to $47.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.9 million, marking a year-over-year decrease of 42.39%. This contributed to the annual value of $102.3 million for FY2025, which is 50.53% down from last year.
  • BIO-TECHNE's Operating Income amounted to $47.7 million in Q3 2025, which was up 299.74% from -$23.9 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Operating Income registered a high of $94.5 million during Q2 2023, and its lowest value of -$23.9 million during Q2 2025.
  • Its 3-year average for Operating Income is $48.3 million, with a median of $47.4 million in 2024.
  • Its Operating Income has fluctuated over the past 5 years, first spiked by 74.46% in 2021, then crashed by 152.07% in 2025.
  • Over the past 5 years, BIO-TECHNE's Operating Income (Quarterly) stood at $62.3 million in 2021, then grew by 8.89% to $67.9 million in 2022, then plummeted by 44.02% to $38.0 million in 2023, then grew by 24.77% to $47.4 million in 2024, then rose by 19.18% to $47.7 million in 2025.
  • Its Operating Income was $47.7 million in Q3 2025, compared to -$23.9 million in Q2 2025 and $38.7 million in Q1 2025.